These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10184833)

  • 1. A question of health. The lottery of cancer care.
    Health Serv J; 1997 Dec; 107(5584):suppl 1-4 following 24. PubMed ID: 10184833
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer Drugs Fund of minimal benefit.
    Burki TK
    Lancet Oncol; 2017 Jun; 18(6):e305. PubMed ID: 28483412
    [No Abstract]   [Full Text] [Related]  

  • 3. Just a private matter.
    Singleton C; Lehane M; Jeffs L; Justice S
    Nurs Stand; 2008 Jul 2-8; 22(43):28-9. PubMed ID: 18655504
    [No Abstract]   [Full Text] [Related]  

  • 4. UK Cancer Drugs Fund to reassess 42 agents.
    Cagney H
    Lancet Oncol; 2015 Jan; 16(1):e8. PubMed ID: 25638560
    [No Abstract]   [Full Text] [Related]  

  • 5. NHS England pulls funding from 25 cancer treatments.
    Kmietowicz Z
    BMJ; 2015 Jan; 350():h214. PubMed ID: 25588769
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost to the NHS of Roche oncology treatments.
    Atkins M
    J R Soc Med; 2007 Jul; 100(7):303. PubMed ID: 17606744
    [No Abstract]   [Full Text] [Related]  

  • 7. UK cancer mystery--the money vanishes.
    Dean M
    Lancet; 2002 Sep; 360(9336):860. PubMed ID: 12243932
    [No Abstract]   [Full Text] [Related]  

  • 8. [Who should receive expensive cancer drugs?].
    Lindekleiv H; Storvik M
    Tidsskr Nor Laegeforen; 2019 Oct; 139(14):. PubMed ID: 31592614
    [No Abstract]   [Full Text] [Related]  

  • 9. Key changes to cancer care in the UK.
    Br J Nurs; 2015 Feb 26-Mar 11; 24(4):S3. PubMed ID: 25723370
    [No Abstract]   [Full Text] [Related]  

  • 10. Government should think again about prioritising seven day NHS services, King's Fund says.
    Torjesen I
    BMJ; 2016 Jul; 354():i3860. PubMed ID: 27402082
    [No Abstract]   [Full Text] [Related]  

  • 11. Top-up payments in cancer care.
    Sikora K; James N
    Clin Oncol (R Coll Radiol); 2009 Feb; 21(1):1-5. PubMed ID: 19038536
    [No Abstract]   [Full Text] [Related]  

  • 12. Cost to the NHS of Roche oncology treatments.
    Sikora K
    J R Soc Med; 2007 Sep; 100(9):396-7. PubMed ID: 17766899
    [No Abstract]   [Full Text] [Related]  

  • 13. British clinic is allowed to deny medicine; decision on cost has broad impact.
    Lyall S
    N Y Times Web; 2006 Feb; ():A10. PubMed ID: 16514743
    [No Abstract]   [Full Text] [Related]  

  • 14. NHS will not pay for drugs that offer little clinical benefit, says cancer fund boss.
    Kmietowicz Z
    BMJ; 2015 Jan; 350():h125. PubMed ID: 25569117
    [No Abstract]   [Full Text] [Related]  

  • 15. Paying for cancer care - a new dilemma.
    Sikora K
    J R Soc Med; 2007 Apr; 100(4):166-9. PubMed ID: 17404337
    [No Abstract]   [Full Text] [Related]  

  • 16. Change ahead for cancer drug funding.
    Lancet Haematol; 2015 Feb; 2(2):e47. PubMed ID: 26687606
    [No Abstract]   [Full Text] [Related]  

  • 17. Lansley is right: age trumps poverty.
    Asthana S
    Health Serv J; 2012 May; 122(6306):16-7. PubMed ID: 22741385
    [No Abstract]   [Full Text] [Related]  

  • 18. Richard Gleave on patients as consumers.
    Gleave R
    Health Serv J; 2008 May; ():26. PubMed ID: 18609779
    [No Abstract]   [Full Text] [Related]  

  • 19. Calling time on the Cancer Drugs Fund? Funding the NHS in the age of austerity.
    Emmerich N
    Br J Hosp Med (Lond); 2015 Apr; 76(4):186-7. PubMed ID: 25853345
    [No Abstract]   [Full Text] [Related]  

  • 20. Cancer Drugs Fund 2.0: A Missed Opportunity?
    McCabe C; Paul A; Fell G; Paulden M
    Pharmacoeconomics; 2016 Jul; 34(7):629-33. PubMed ID: 27002519
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.